Indo Borax & Chemicals Ltd (INDOBORAX) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Indo Borax & Chemicals Ltd on NSE and BSE, with an AI summary of each filing.
Disclosure under Regulation 30 of the SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015 - Updation regarding Creation of pledge over equity shares held in Kronox ....
Others (Uncategorized) · 04 Nov 2026, 12:13 am
Indo Borax Pledges 14% Stake in Kronox Lab Sciences for ₹225 Crore Loan Indo Borax & Chemicals created a pledge on 51,94,560 equity shares, representing approximately 14% of the paid-up equity share capital of Kronox Lab Sciences, on 3rd Nov'26. The pledge acts as collateral for a ~₹225 crore term loan facility availed by Indo Borax to finance its acquisition of equity shares in Kronox. The transaction causes no change in Indo Borax's shareholding or control, and Kronox continues to remain a subsidiary.
To consider and approve the financial results for the period ended September 30, 2026 and other business matters
Intimation · 06 Nov 2026, 5:30 am
INDO BORAX & CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 06-Nov-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business.
Intimation · 06 Nov 2026, 5:30 am
Indo Borax & Chemicals Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve the Unaudited Financial ....
Intimation · 06 Nov 2026, 5:30 am
Indo Borax & Chemicals Schedules Board Meeting for Q2 FY27 Results Indo Borax & Chemicals Ltd has scheduled its Board of Directors meeting for 6th Nov'26 to consider, approve, and take on record the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the insider trading window, which closed on 1st Oct'26, will reopen 48 hours after the formal declaration of the financial results.
Disclosure under regulation 30 read with Schedule III of SEBI (LODR) Regulations, 2015-Amendment of the Share Purchase Agreement
Others (Uncategorized) · 23 Oct 2026, 1:40 am
Indo Borax Amends SPA for Kronox Lab Sciences Acquisition Indo Borax & Chemicals Limited executed an amendment agreement on 22nd Oct'26 to modify its 20th Aug'26 Share Purchase Agreement with Zenrock Chemicals and erstwhile promoters of Kronox Lab Sciences Limited. The amendment removes Clause 9.5 (lock-in on sellers' shareholding) and Clause 9.6 (right of first refusal), eliminating lock-in restrictions on the sellers' retained 9.95% stake and terminating Indo Borax’s right of first refusal. Indo Borax and Zenrock Chemicals became promoter and promoter group entities of Kronox Lab Sciences on 29th Sep'26.
Intimation under Regulation 30 of the SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015 - Creation of pledge over equity shares held in Kronox Lab Sciences Limited, ....
Others (Uncategorized) · 19 Oct 2026, 9:21 pm
Indo Borax Pledges 14% Stake in Kronox Lab Sciences for ₹225 Crore Loan Indo Borax & Chemicals Ltd. created a pledge on 19th Oct'26 over 51,94,560 equity shares of its subsidiary, Kronox Lab Sciences Ltd., representing ~14% of Kronox's paid-up equity capital. The pledge serves as security for a ₹225 crore term loan facility availed to finance the acquisition of Kronox shares. Indo Borax currently holds 2,38,44,000 shares, or 64.26%, in Kronox. The transaction results in no change in shareholding or management control, with Kronox remaining a subsidiary.
Pursuant to regulation 30 of the SEBI (LODR) please find attached press release dated 1st October, 2026
Press Release · 01 Oct 2026, 11:29 pm
Indo Borax Completes 64.26% Stake Acquisition in Kronox Lab Sciences Indo Borax & Chemicals completed the acquisition of a 64.26% controlling stake in Kronox Lab Sciences on 29th Sep'26, while erstwhile promoters retained 9.95%. Following the acquisition, Indo Borax reconstituted the board and appointed Suresh Kalra as MD & CEO for five years, alongside Shashikant Bharuka as CFO. Kronox manufactures high-purity speciality fine chemicals with a portfolio exceeding 185 products, generating approximately INR 101 crore in revenue and INR 28 crore in PAT for FY26.
Completion of the acquisition of 64.26% of the share capital of Kronox Lab Sciences Limited.
Others (Uncategorized) · 29 Sept 2026, 9:14 pm
Indo Borax & Chemicals Completes Acquisition of 64.26% Stake in Kronox Lab Sciences Indo Borax & Chemicals Limited has completed the acquisition of 2,38,44,000 equity shares, representing a 64.26% controlling stake in the paid-up equity share capital of Kronox Lab Sciences Limited, on 29th Sep'26. The transaction follows the share purchase agreement executed on 20th Aug'26 with the selling shareholders (Ketan Vinodchandra Ramani, Pritesh Vinodchandra Ramani, and Jogindersingh Gianchand Jaswal) alongside Zenrock Chemicals Private Limited. All other material transaction details disclosed in the initial regulatory filing remain unchanged.
Availed funding from a lending institution for the purpose of financing the acquisition of equity shares of Kronox Lab Sciences Limited.
Others (Uncategorized) · 24 Sept 2026, 9:15 pm
Indo Borax Secures ₹225 Crore Debt Funding for Kronox Lab Sciences Acquisition Indo Borax & Chemicals Limited has secured ₹225 crore in funding from a lending institution on 23rd Sep'26. The capital will be utilized entirely to finance the previously disclosed acquisition of equity shares in Kronox Lab Sciences Limited. The company confirmed it will provide further disclosures in accordance with SEBI Listing Regulations as developments progress.
Intimation of Analyst/Institutional Investor Meet/Conference
Intimation · 24 Sept 2026, 12:13 am
Indo Borax & Chemicals Schedules Virtual Investor Group Meeting Indo Borax & Chemicals Ltd. officials are scheduled to participate in a virtual group investor meeting on 28th Sep'26 from 12:00 PM to 1:00 PM. The interaction is organized by Arihant Capital under the Bharat Connect Conference: Rising Stars. The discussions will center strictly around publicly available information with no unpublished price-sensitive information (UPSI) involved.
Transcript of the Investor/Analyst Earnings Call held on Wednesday, September 02, 2026.
Transcript · 08 Sept 2026, 9:22 pm
Intimation of audio recording of Analysts/Institutional Investors/Organisations meet - ''''Earnings Call''''.
Audio / Video · 03 Sept 2026, 2:14 am
Indo Borax & Chemicals Uploads Audio Recording for Q1FY27 Earnings Call Indo Borax & Chemicals Ltd. has made the audio recording available for its Q1FY27 earnings call held on 2nd Sep'26. The session covered the company's un-audited standalone and consolidated financial results for the quarter ended 30th Jun'26. The audio recording link is now accessible on the company's official website for analysts and investors.
Investor Presentation for the quarter ended June 30, 2026.
Investor Presentation · 01 Sept 2026, 11:34 pm
Indo Borax Q1FY27: Strong YoY Growth Driven by Higher Realizations & Demand Indo Borax & Chemicals posted strong Q1FY27 results, with consolidated revenue up 31.34% YoY to Rs. 70.36 Cr. EBITDA grew 62.16% YoY to Rs. 19.80 Cr, with margins expanding to 28.14%. Net profit rose 59.31% YoY to Rs. 16.25 Cr, yielding an EPS of Rs. 5.07. Performance was driven by improved capacity utilization, higher realizations, and steady domestic demand. Post-quarter, the board approved the acquisition of 64.26% of Kronox Lab Sciences for Rs. 246.12 Cr to support premiumization, diversification, and margin improvement.
Intimation on revision in Credit rating as per Regulation 30 read with Part A of Schedule III to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Others (Uncategorized) · 01 Sept 2026, 12:43 am
Indo Borax Placed on Rating Watch Negative on KLSL Acquisition Plans India Ratings has placed Indo Borax & Chemicals’ (IBCL) INR 600mn bank loan facilities on Rating Watch with Negative Implications, changing the outlook from Stable. This follows the 20 Aug'26 announcement to acquire a 64.26% promoter stake in Kronox Lab Science for INR 2,461.2mn, likely funded by INR 2,250mn in debt. The watch also reflects an open offer for an additional 25.79% stake. Key concerns include a 100% promoter share pledge to secure parent ZCPL's debt and the financial impact of the acquisition.
Intimation regarding Corporate Office address and maintenance of the Books of Account and relevant books and papers of the Company at the Corporate Office address of the Company.
Others (Uncategorized) · 01 Sept 2026, 12:26 am
Indo Borax & Chemicals Establishes New Corporate Office Indo Borax & Chemicals' Board approved the establishment of a new corporate office on Aug 31, 2026. Effective Sep 15, 2026, the new office will be located at Office No. 201-A, 2nd Floor, Vedanta, 779, Makwana Road, Marol, Andheri (East), Mumbai. The company's books of account and other relevant papers will also be maintained at this new address. This action complies with Regulation 30 of SEBI's Listing Regulations, 2015.
Earnings call with the Analysts/Investors on the Un-Audited (Standalone and Consolidated) Financial Results of the Company for the quarter ended June 30, 2026.
Intimation · 02 Sept 2026, 4:00 pm
Indo Borax & Chemicals Schedules Q1FY27 Earnings Call Indo Borax & Chemicals will host an earnings call for analysts and investors on 02 Sep'26 at 4:00 PM IST. The management will discuss the un-audited standalone and consolidated financial results for the first quarter ended 30 Jun'26 (Q1FY27). This follows the company's official regulatory filing on 27 Aug'26.
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Press Release ....
Press Release · 20 Aug 2026, 9:01 pm
Indo Borax to Acquire 64.26% Stake in Kronox Lab Sciences Indo Borax announced on 20 Aug'26 its plan to acquire a 64.26% stake in Kronox Lab Sciences for Rs. 246.12 crore. The transaction involves purchasing 2,38,44,000 equity shares. Additionally, Indo Borax and its promoter Zenrock Chemicals will launch an open offer to acquire a further 25.79% stake in Kronox. The acquisition aims to enhance Indo Borax's expansion, diversification, and margin profile. Post-transaction, Kronox's promoters will retain a 9.95% stake and provide transition support. The deal is expected to close within three months.
Acquisition and Open Offer
Others (Uncategorized) · 20 Aug 2026, 5:48 pm
Indo Borax to Acquire Controlling Stake in Kronox Lab Sciences On 20-Aug-26, Indo Borax & Chemicals announced the acquisition of a 64.26% stake in Kronox Lab Sciences for ₹246.12 Cr. The deal involves purchasing 2.38 Cr shares from Kronox's promoters at ₹103.22 per share. This acquisition is part of Indo Borax's long-term strategy to diversify into the high-purity specialty fine chemicals sector. Following the acquisition, Indo Borax will launch a mandatory open offer to acquire an additional 25.79% stake from public shareholders, with completion expected within three months.
For Acquisition and Open Offer.
Others (Uncategorized) · 20 Aug 2026, 5:45 pm
Indo Borax to Acquire 64.26% of Kronox Lab Sciences, Triggers Open Offer On Aug 20, '26, Indo Borax & Chemicals' board approved acquiring a 64.26% stake (2.38 crore shares) in Kronox Lab Sciences for ₹246.11 Cr, at ₹103.22 per share. The acquisition aims to diversify Indo Borax's portfolio into high-purity specialty fine chemicals. This transaction triggers a mandatory open offer to acquire an additional 25.79% stake (95.70 lakh shares) from public shareholders. The deal is not a related-party transaction and is expected to be completed within three months of the public announcement.
Press Release-Un-audited Financial Results for the quarter ended June 30, 2026
Press Release · 11 Aug 2026, 1:20 am
Indo Borax Q1FY27 Net Profit Surges 59% on Strong Demand and Margin Expansion Indo Borax & Chemicals reported strong Q1FY27 results, with net profit surging 59.3% YoY to ₹16.25 crore on 10 Aug'26. Operating income grew 31.3% YoY to ₹70.36 crore, driven by robust demand and higher capacity utilization. EBITDA increased 62.2% YoY to ₹19.80 crore. Margin expansion was significant, with EBITDA margin rising 530 bps to 28.1% and PAT margin up 430 bps to 22.3%. The board also approved the amalgamation of its wholly-owned subsidiary, Indoborax Infrastructure, with the parent company.
Unaudited Financial Results for the quarter ended June 30, 2026.
Financial Result · 10 Aug 2026, 7:24 pm
Indo Borax Reports Strong Q1'27 Results with 59% YoY Net Profit Growth Indo Borax & Chemicals posted strong consolidated results for Q1'27 (quarter ended 30-Jun'26), with Net Profit rising 59% YoY to ₹1,625.40 lakhs. Revenue from operations grew 31% YoY to ₹7,035.61 lakhs. Profit Before Tax (PBT) increased 53% YoY to ₹2,200.03 lakhs. Sequentially, Net Profit was up 12% QoQ from ₹1,453.23 lakhs. EPS for the quarter improved to ₹5.07, compared to ₹3.18 in the same quarter last year. The Board also approved a draft Postal Ballot for shareholder approval.
Outcome of Board Meeting held today i.e. August 10, 2026.
Outcome · 10 Aug 2026, 7:09 pm
Indo Borax & Chemicals Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) ■ Revenue: 7,036 (+31.3% YoY | +11.7% QoQ) ■ EBITDA: 1,980 (+62.1% YoY | +54.4% QoQ) ■ EBITDA Margin (%): 28.1 (+535 bps YoY | +779 bps QoQ) ■ PAT: 1,625 (+59.3% YoY | +11.8% QoQ) ■ EPS (INR): 5.07 (+59.4% YoY | +11.9% QoQ)
Indo Borax & Chemicals Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve Indo Borax & Chemicals ....
Intimation · 10 Aug 2026, 5:30 am
Indo Borax & Chemicals Board Meeting Set for Q1 Results Indo Borax & Chemicals has scheduled a Board of Directors meeting for 10 Aug'26 to consider and approve the Unaudited Financial Results for the quarter ending 30 Jun'26. In compliance with insider trading regulations, the trading window for designated persons has been closed since 01 Jul'26. The window will reopen 48 hours after the financial results are declared.
Scrutinizer''s Report - Annual General Meeting
Annual General Meeting · 30 Jul 2026, 12:27 am
Proceedings of 45th AGM held on Tuesday, July 28, 2026.
Annual General Meeting · 28 Jul 2026, 11:50 pm